These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 38880672)
1. Potentiation of the muscarinic acetylcholine receptor 1 modulates neurophysiological features in a mouse model of Rett syndrome. Dong HW; Weiss K; Baugh K; Meadows MJ; Niswender CM; Neul JL Neurotherapeutics; 2024 Jul; 21(4):e00384. PubMed ID: 38880672 [TBL] [Abstract][Full Text] [Related]
2. Detection of neurophysiological features in female R255X MeCP2 mutation mice. Dong HW; Erickson K; Lee JR; Merritt J; Fu C; Neul JL Neurobiol Dis; 2020 Nov; 145():105083. PubMed ID: 32927061 [TBL] [Abstract][Full Text] [Related]
3. Clinical and Preclinical Evidence for M Smith M; Arthur B; Cikowski J; Holt C; Gonzalez S; Fisher NM; Vermudez SAD; Lindsley CW; Niswender CM; Gogliotti RG Neurotherapeutics; 2022 Jul; 19(4):1340-1352. PubMed ID: 35670902 [TBL] [Abstract][Full Text] [Related]
4. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109 [TBL] [Abstract][Full Text] [Related]
5. Sensory evoked potentials in patients with Rett syndrome through the lens of animal studies: Systematic review. Sysoeva OV; Smirnov K; Stroganova TA Clin Neurophysiol; 2020 Jan; 131(1):213-224. PubMed ID: 31812082 [TBL] [Abstract][Full Text] [Related]
6. Cellular origins of auditory event-related potential deficits in Rett syndrome. Goffin D; Brodkin ES; Blendy JA; Siegel SJ; Zhou Z Nat Neurosci; 2014 Jun; 17(6):804-6. PubMed ID: 24777420 [TBL] [Abstract][Full Text] [Related]
7. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047 [TBL] [Abstract][Full Text] [Related]
8. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome. Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186 [TBL] [Abstract][Full Text] [Related]
9. The relationship of Rett syndrome and MECP2 disorders to autism. Neul JL Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951 [TBL] [Abstract][Full Text] [Related]
10. Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies. Smirnov K; Stroganova T; Molholm S; Sysoeva O Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069993 [TBL] [Abstract][Full Text] [Related]
11. Effect of positive allosteric modulation and orthosteric agonism of dopamine D2-like receptors on respiration in mouse models of Rett syndrome. Maletz SN; Reid BT; Baekey DM; Whitaker-Fornek JR; Bateman JT; Arakawa K; Bissonnette JM; Levitt ES Respir Physiol Neurobiol; 2024 Oct; 328():104314. PubMed ID: 39117159 [TBL] [Abstract][Full Text] [Related]
12. ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. Kaufmann WE; Sprouse J; Rebowe N; Hanania T; Klamer D; Missling CU Pharmacol Biochem Behav; 2019 Dec; 187():172796. PubMed ID: 31704481 [TBL] [Abstract][Full Text] [Related]
13. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes. Flores Gutiérrez J; Natali G; Giorgi J; De Leonibus E; Tongiorgi E Exp Neurol; 2022 Jul; 353():114056. PubMed ID: 35358499 [TBL] [Abstract][Full Text] [Related]
14. Optimized Administration of the M Cikowski J; Holt C; Arthur B; Smith M; Gonzalez S; Lindsley CW; Niswender CM; Gogliotti RG ACS Chem Neurosci; 2022 Jul; 13(13):1891-1901. PubMed ID: 35671352 [TBL] [Abstract][Full Text] [Related]
16. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. Cuddapah VA; Pillai RB; Shekar KV; Lane JB; Motil KJ; Skinner SA; Tarquinio DC; Glaze DG; McGwin G; Kaufmann WE; Percy AK; Neul JL; Olsen ML J Med Genet; 2014 Mar; 51(3):152-8. PubMed ID: 24399845 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome. Cosentino L; Urbinati C; Lanzillotta C; De Rasmo D; Valenti D; Pellas M; Quattrini MC; Piscitelli F; Kostrzewa M; Di Domenico F; Pietraforte D; Bisogno T; Signorile A; Vacca RA; De Filippis B Mol Autism; 2024 Sep; 15(1):39. PubMed ID: 39300547 [TBL] [Abstract][Full Text] [Related]
18. Visual evoked potentials detect cortical processing deficits in Rett syndrome. LeBlanc JJ; DeGregorio G; Centofante E; Vogel-Farley VK; Barnes K; Kaufmann WE; Fagiolini M; Nelson CA Ann Neurol; 2015 Nov; 78(5):775-86. PubMed ID: 26332183 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model. Ribeiro MC; MacDonald JL Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041 [TBL] [Abstract][Full Text] [Related]